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The paraventricular nucleus of the thalamus (PVT) projects to the central nucleus
of the amygdala and recent experimental evidence indicates a role for the PVT in
conditioned fear. Furthermore, the PVT contains a high density of orexin receptors
and fibers and acute injections of orexin antagonist into the PVT produce anxiolytic
effects. The present study was done to determine if administration of a dual orexin
receptor antagonist (DORA) in the region of the PVT interferes with the expression of
conditioned fear in rats exposed to cued and contextual conditioning paradigms. Infusion
of 0.5 µl of the DORA N-biphenyl-2-yl-1-[(1-methyl-1H-benzimidazol-2yl) sulfanyl] acetyl-
L-prolinamide at a concentration of 0.1, 1.0, and 10 nmol had no effect on the freezing
produced by exposing rats to an auditory cue or the context associated with foot
shock. In contrast, the 1.0 and 10 nmol doses were anxiolytic in the social interaction
test. The results of the present study do not support a role for orexin receptors in
the PVT in the expression of learned fear. The finding that the 1.0 and 10 nmol
doses of DORA in the PVT region were anxiolytic in the social interaction test is
consistent with other studies indicating a role for orexins in the PVT in anxiety-like
behaviors.
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Introduction
Orexins (hypocretins), which consist of the bioactive orexin-A and orexin-B peptides, are
synthesized exclusively in neurons in the hypothalamus. These peptides act at G-protein
coupled receptors called the orexin-1 (OX1R) and the orexin-2 receptors (OX2R). The orexin
peptides play a key role in maintaining aroused states and accumulating evidence demonstrates
that orexins are involved in the regulation of motivated behavior including food intake and
drug seeking (Boutrel et al., 2010; Mahler et al., 2014; Sakurai, 2014). Other evidence shows
that orexin neurons are activated in response to stressful conditions (Winsky-Sommerer et al.,
2004) and that orexins contribute to anxiety-like behaviors. For instance, systemic injections
of the OX1R antagonist SB334867 blocked the behavioral and autonomic responses elicited in
a rat model of panic (Johnson et al., 2010). In other studies, acute systemic injections of the
dual orexin receptor antagonist (DORA) TCS-1102 reduced contextual fear as well as the defensive
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and avoidance behaviors in rats previously exposed to
footshocks (Chen et al., 2014b). In other studies, chronic oral
administration of another DORA called almorexant reduced
anxiety after footshock exposure (Viviani et al., 2015) while an
acute oral treatment with almorexant attenuated fear in a fear-
potentiated startle paradigm (Steiner et al., 2012). The location
where the DORA acts to reduce fear is poorly understood
but recent reports have identified the locus coeruleus as a
brain area where orexins are involved in the acquisition of
cue-dependent fear memory (Sears et al., 2013; Soya et al.,
2013).
The paraventricular nucleus of the midline thalamus (PVT)
is a midline thalamic nucleus that receives among the densest
orexin inputs in the brain and represents an area where
orexins can act to regulate defensive behaviors. The PVT
sends a dense projection to the central nucleus of the
amygdala (CeA) and the bed nucleus of the stria terminalis
(BST; Li and Kirouac, 2008; Vertes and Hoover, 2008),
areas of the brain that play a key role in mediating fear
and anxiety (Wilensky et al., 2006; Davis et al., 2010).
Furthermore, the PVT projects to the basolateral amygdala,
prelimbic cortex and infralimbic cortex (Li and Kirouac, 2008;
Vertes and Hoover, 2008), which are known to regulate
emotional reactions like fear and anxiety (Burgos-Robles et al.,
2009; Sotres-Bayon and Quirk, 2010). More importantly,
administrations of orexins in the posterior aspect of the PVT
(pPVT) was shown to increase anxiety whereas injections
of the OX2R antagonist TCSOX229 was reported to have
an acute anxiolytic effect in rats after a previous exposure
to footshock stress (Li et al., 2010a,b; Heydendael et al.,
2011). Experimental evidence provided from studies using
lesion or temporal inactivation in the PVT region also
showed that the PVT is involved in the expression of
fear to a tone previously paired with footshocks (Padilla-
Coreano et al., 2012; Li et al., 2014; Do-Monte et al.,
2015; Penzo et al., 2015). Optogenetics or chemogenetics
approaches indicated that neurons in the PVT regulated fear
expression by a projection to the central amygdala (Do-Monte
et al., 2015; Penzo et al., 2015). However, the contribution
of orexins in the PVT to conditioned fear has not been
investigated.
The present study investigated the effect of blocking orexin
receptors in the PVT on the fear associated with cued and
contextual conditioning procedures. The purpose of the first
experiment was to determine if orexin receptors in the PVT
contribute to fear to an auditory tone produced by a conditioning
protocol similar to the one used to show an involvement
of the PVT in fear (Padilla-Coreano et al., 2012; Li et al.,
2014; Do-Monte et al., 2015). The second experiment was
done to examine the contribution of orexin receptors in the
PVT to the fear associated with the shock chamber using a
contextual fear protocol known to cause the activation of the
orexin system (Chen et al., 2014a,b). Consequently, the effect
of blocking orexin receptors in the PVT on the anxiety that
resulted from the contextual conditioning procedure was used
to determine the effectiveness of orexin antagonist used in the
present experiment.
Methods
Animals and Housing
A total of 95 adult male Sprague-Dawley rats (Vital River
Laboratory Animal Technology Co. Ltd., Beijing, China) were
used for the experiments. The rats (weighing 200–220 g upon
arrival) were housed individually in cages with food and water
ad libitum in a room set on a 12 h/12 h light/dark (lights
on at 08:00) cycle with controlled temperature (20–24◦C) and
humidity (40–70%). The rats were handled for 2 min on alternate
days during a 7-day adaption period. All the procedures were
conducted according to the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. The protocols
were approved by the Research Ethics Committee of Institute of
Psychology, Chinese Academy of Sciences.
Surgery
The rats were anesthetized with sodium pentobarbital (60 mg/kg,
2 ml/kg, i.p.; Sigma-Aldrich) and placed in a stereotaxic frame
(RWD Life Science Co., Ltd., Shenzhen, Guangdong, China).
Stainless steel guide cannulas (23 gauge, RWD Life Science Co.,
Ltd.) were unilaterally implanted into the posterior aspect of the
PVT (3.1 mm posterior to bregma, 1.3 mm lateral to the midline,
and 4.0 mm ventral to the skull, angled at 10◦ with the incisor
bar set at 3.3 mm below intraaural line). The guide cannulas were
secured with three small screws attached to the skull and dental
cement. Capped stylets were inserted into the guide cannulas
and all rats were treated with penicillin (80,000 units) to prevent
infection. The rats were allowed to recover for 7–10 days and
were handled every other day to reduce stress associated with
handling.
Drugs and Microinjections
The DORA used for the experiments was a compound called
N-biphenyl-2-yl-1-[(1-methyl-1H-benzimidazol-2yl) sulfanyl]
acetyl-L-prolinamide which was first prepared and describe by
Merck Research Laboratories (Bergman et al., 2008; TCS-1102,
cat# 3818; MW = 470.59, Tocris, Minneapolis, MN, USA) which
was dissolved in poly-ethylene glycol 200 (PEG200, Beijing
Chemical Works, Beijing, China). TCS-1102 blocks both OX1R
(IC50 = 4 nM) and OX2R (IC50 = 17 nM) and has been shown
to be effective in blocking orexin-mediated behaviors for up to
4 h (Bergman et al., 2008; Winrow et al., 2010). The drug and
vehicle were microinjected into the PVT (0.5 µl) through an
injector cannula (28 gauge, RWD Life Science Co., Ltd.) which
protrudes 2.0 mm below the guide cannula. Infusions were
delivered with a 5.0 µl Hamilton microsyringe connected to
the injector cannula with polyethylene tubing and an infusion
pump was used to deliver the drug at the rate of 0.2 µl/min over
2.5 min. The injector cannula was kept in the guide cannula
for another minute to prevent backflow before the stylet was
placed back into the guide cannula and the rat was returned to
its home cage.
Footshock and Behavioral Procedures
Footshocks were given in an acrylic black chamber (30 ×
30 × 27 cm) with a grid floor (Beijing MacroAmbition S&T
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Development Co., Ltd., Beijing, China) which was illuminated at
200–300 lux. The rats were acclimated to the shock chamber for
180 s before receiving a series of footshocks.
Experiment 1. A cued fear conditioning protocol was used in
which rats were exposed to a total of eight 30 s tones (4 kHz,
75 dB) that co-terminated with a 0.5 s shock of 0.65 mA (inter
trial interval = 120 ± 30 s). The rats were assigned to four
homogeneous groups based on their freezing time during fear
learning. Fear expression to the tone was tested 24 h later in
rats that had received a microinjection of the DORA into the
PVT region approximately 30 min before being placed in the
same chamber that was used for conditioning. The rats received
the DORA at 0.1, 1.0, and 10 nmol or the vehicle. Each rat
was exposed to the tone 20 times (inter trial interval of 60 ±
30 s). Fear extinction recall was examined 24 h later by exposing
the rats to 10 tones in the shock chamber. The purpose of
the extinction recall experiment was to examine if the DORA
interfered with the consolidation processes of the extinction
memory. The freezing response, which was defined as no
movement except for those related to respiration, was recorded
by a video tracking system (XeyeFCs, Beijing MacroAmbition
S&T Development Co., Ltd., Beijing, China) and was used as a
measure of fear.
Experiment 2. A contextual fear conditioning protocol was
used in which rats were exposed to five 5 s footshocks of
1.5 mA (intershock interval of 120 ± 30 s). Animals were
returned to their home cages 60 s after the last footshock.
The choice to use more intense footshocks for the contextual
conditioning experiment was based on previous evidence that
exposure of 1.5 mA footshocks produces an orexin-mediated
fear and anxiety (Chen et al., 2014b). For example, exposure
of rats to footshocks of this intensity has been shown to
produce long-lasting increases in prepro-orexin mRNA as well
as contextual fear and anxiety that are attenuated by systemic
injections of a DORA (Chen et al., 2014b). Rats were assigned
to drug treatment groups as described for Experiment 1. Fear
expression was examined 24 h later by placing the rat in
the shock chamber for 10 min following microinjections of
the drug in the PVT region. Fourteen days later, the animals
were reassigned to four groups randomly and microinjections
of one of three different doses of the DORA or the vehicle
were made in the PVT region before the behavior of the
rats was examined consecutively in the open field and social
interaction tests. Note that TCS 1102 was shown to block
orexin receptors for at least 4 h after administration (Winrow
et al., 2010). Thirty minutes later, the rats were placed in a
circular open field (100 cm in diameter, 50 cm high, with
15–20 lux illumination) for 5 min. The activity of the rats was
recorded by the video tracking system for subsequent analysis
of locomotor activity, latency to the center area, and time spent
in the center area. After the open field test, the rats were
transferred to another room for the social interaction test. The
social interaction arena was a black rectangle open field (100 cm
long × 60 cm wide, 5–10 lux illumination). A stimulus rat (male
rat weighing 450–500 g) was put into a small mesh box in a
corner of the arena, and the test rat was placed in an enclosed
compartment located in the opposite corner. After a 2 min
habituation period, the sliding door of the enclosed box was
opened, allowing the test rat to move freely in the arena for
5 min. The time spent in the social zone (20 × 30 cm zone
immediately adjacent to the target rat compartment) and the
latency to come out of the box was recorded by the video tracking
system.
Cannula Verification
Rats were deeply anesthetized with chloral hydrate (50 mg/kg)
prior to decapitation. The brains were removed, post-
fixed overnight in 4% paraformaldehyde and subsequently
cryoprotected in 30% sucrose solution in 0.1 M phosphate
buffer (PB) at 4◦C. Serial coronal sections (60 µm) were cut
using a freezing microtome and subsequently stained for
Nissl substance using Cresyl Violet. Two examples of cannula
placement are shown in Figure 1 and the locations for all cases
in the two experiments are shown in Figure 2. Data of rats
FIGURE 1 | Examples of the location of injector tips in the thalamus.
The pictures show two examples of placements of the injector tip (arrows) in
the region of the paraventricular nucleus of the thalamus (PVT) as verified from
histological sections. Scale bar = 0.5 mm.
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FIGURE 2 | Location of injector cannulas in the midline thalamus. The
diagram shows the location of the injector tips in the region of the PVT as
verified from histological sections. The numbers correspond to distance from
bregma. CM, centromedial nucleus; IMD, intermediodorsal nucleus; Hb,
habenular complex; MD, mediodorsal nucleus.
with misplaced cannula were excluded (three in Experiment 1,
six in Experiment 2), only rats with injection sites near the
PVT were used for statistical analysis (Experiment 1: 0.1 nmol
n = 13, 1.0 nmol n = 12, 10 nmol n = 11, vehicle n = 14;
Experiment 2: 0.1 nmol n = 7, 1.0 nmol n = 10, 10 nmol
n = 10, vehicle n = 9; Experiment 2 reassignment for anxiety
tests 0.1 nmol n = 10, 1.0 nmol n = 7, 10 nmol n = 10, vehicle
n = 9).
Statistical Analysis
The freezing responses during the presentation of the tone for the
extinction and extinction recall sessions (Experiment 1; freezing
for each trial consisting of two consecutive tone presentations) as
well as the freezing to the shock chamber (Experiment 2; each
data point consisting of a 2.5 min time period) were analyzed
using an ANOVA with repeated-measures. For Experiment 2,
the total amount of freezing in the shock chamber, locomotion
in the open field and time spent in social zone were analyzed
by one-way ANOVA with Bonferroni post hoc tests used
for multiple comparisons. The latency in the open field test
and in the social interaction test were analyzed by Kruskal-
Wallis one-way analysis of variance by ranks followed by
Mann-Whitney test to determine which group was statistically
different. Statistical analysis was done with SPSS 20.0 software
and data are presented as the mean ± standard error of the
mean.
Results
Experiment 1
In Experiment 1, exposure of rats to tones paired with footshocks
resulted in increasing amounts of freezing with conditioning
trials (F(3,138) = 68.3, p< 0.001; Figure 3). Repeated presentation
of the conditioning tone produced a significant extinction
effect (main effect of extinction in repeated-measures ANOVA
F(9,414) = 13.3, p< 0.001; Figure 3) and the DORA did not affect
fear expression during the first tone presentation (F(3,46) = 0.51,
p = 0.66; Figure 3) nor the fear extinction in the extinction
trials that followed (F(3,46) = 1.68, p = 0.18). In addition,
there was no interaction between the trials and DORA doses
F(27,414) = 1.13, p = 0.30; Figure 3). The pre-tone baseline level
of freezing in the chamber was unaffected by the DORA (vehicle
21.7%, 0.1 nmol 26.9%, 1.0 nmol 21.2%, and 10 nmol 20.7%;
F(3,46) = 0.17, p = 0.92). There were no group differences in the
recall of the extinction memory 24 h after the extinction phase
(F(3,46) = 1.512, p = 0.22; Figure 3), nor was there an interaction
between doses of DORA and the trials (F(12,184) = 0.70, p = 0.75;
Figure 3).
Experiment 2
A contextual fear conditioning paradigm using footshocks with
an intensity of 1.5 mA produces fear to the shock context
(contextual fear condition) and anxiety in tests involving
approach-avoidance behaviors (Chen et al., 2012). Consequently,
we used this paradigm to investigate the role of orexin
receptors in the PVT in fear and anxiety. In terms of the
contextual fear expression 24 h after fear conditioning, the
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FIGURE 3 | Effect of injections of a DUAL OREXIN RECEPTOR
ANTAGONIST (DORA) in the region of the PVT on freezing in cued fear
conditioning. Rats were fear conditioned on Day 1 and freezing to the tone
was examined on Day 2 following injections of the vehicle or one of the 0.1, 1.0,
and 10 nmol concentrations of the DORA. The drug had no effect on fear
expression or fear extinction. In addition, the drug treatment on Day 2 had no
effect on the extinction recall on Day 3. Each data point represents the mean of
two trials and results are presented as mean ± SEM.
DORA had no effect on fear to the shock chamber (freezing
in four 2.5 min time periods F(3,32) = 0.72, p = 0.55,
interaction between time and DORA doses F(9,96) = 0.15,
p = 0.99; total freezing for the 10 min in the shock chamber
F(3,32) = 1.01, p = 0.40; Figure 4). However, in the social
interaction test, the Kruskal-Wallis one-way ANOVA indicated
a main effect for the DORA (χ2(3) = 11.78, p = 0.008;
Figure 5A) with the 1.0 nmol (p = 0.038) and 10 nmol
(p = 0.003) doses decreasing the latency to enter the social
interaction zone. The time spent in the social zone was not
significantly increased in groups with DORA (F(3,32) = 1.47,
p = 0.24; Figure 5A). In the open field test, the DORA had
no effect on the latency to go to the center (χ2(3) = 5.55,
p = 0.14; Figure 5B) but the one-way ANOVA revealed
a main effect of drug dose on locomotion (F(3,32) = 3.27,
p = 0.034; Figure 5B) with the highest dose significantly
increasing locomotion (p = 0.024). In summary, the DORA
had an anxiolytic effect but had no effect on contextual fear
expression.
Discussion
The present study investigated the role of orexin receptors in
the PVT in cued and contextual fear conditioning. The results
show that microinjections of a DORA in the PVT did not
attenuate the fear expressed following exposure of rats to cued
and contextual fear conditioning paradigms. A lack of an effect
on contextual fear was surprising considering that the protocol
used was the same as the one used to show that systemic
injections of the same DORA reduced contextual fear (Chen
et al., 2014b). However, the DORA had an anxiolytic effect
when the contextual fear conditioned rats were tested in a social
interaction test. These results indicate that orexin receptors in the
PVT are not involved in learned fear expression but play a role in
anxiety.
A number of studies have shown that the PVT is involved in
the expression of a learned fear or the retrieval of a fear memory
FIGURE 4 | Effect of injections of a DORA in the PVT region in
contextual fear conditioning. Rats were exposed to footshock and the
amount of freezing to the shock chamber was examined on Day 2 following
injections of the vehicle or one of the 0.1, 1.0, and 10 nmol concentration of
the DORA. The drug had no effect on fear expression. The results are
presented as mean ± SEM.
in the cued conditioning model (Padilla-Coreano et al., 2012;
Li et al., 2014; Do-Monte et al., 2015; Penzo et al., 2015) while
other studies indicate a role for orexin receptors in the PVT
in anxiety (Li et al., 2010a,b; Heydendael et al., 2011). As such,
we tested the possibility that orexin receptors in the PVT were
involved in learned fear. However, the results of the experiments
indicate that orexin receptors in the PVT are not necessary for
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FIGURE 5 | Effect of injections of a DORA in the region of the PVT on
avoidance. (A) The 1.0 and 10 nmol concentrations of the DORA decreased
the latency for rats to enter the social zone in the social interaction test while
the same doses did not significantly affect the time spent in the social zone.
(B) Injections of the DORA did not have a significant effect on the
(Continued)
FIGURE 5 | Continued
latency to enter the center of the open field while the 10 nmol concentration
increased the amount of locomotion. Note that injections of the DORA were
made in the PVT prior to exposing the rats consecutively to the open field and
social interaction tests. *p < 0.05; **p < 0.01. Results are presented as
mean ± SEM.
the expression of cued fearmemory. This conclusion is consistent
with the previous experimental evidence that demonstrated that
the orexin system is not involved in cued fear expression or
memory recall (Sears et al., 2013; Soya et al., 2013). For example,
cued fear expression was reported to be unaffected by a prior
intracerebroventricular (ICV) infusion of the OX1R antagonist
SB334867 in rats trained using a weak training protocol (3 ×
0.5 mA 2 s footshocks; Sears et al., 2013). In addition, OX2R
knock-out mice display a similar level of fear learning and
expression as wild type animals when they are exposed to a cued
fear conditioning paradigm with mild footshocks (Soya et al.,
2013). Taken together, it does not appear that the orexin system
contributes to the freezing associated with discriminative fear
conditioning. It is possible that the orexin system is involved
in other types of response associated with discriminative fear
paradigms since other studies have reported that an acute oral
administration of another DORA attenuated a conditioned fear
potentiated startle response (Steiner et al., 2012). In that study
the conditioning training session contained more trials (15 pairs
each session) and trained the rats two or four times before the fear
potentiated startle test. The relatively prolonged training session
might result in a more robust fear memory possibly through
mechanisms involving the orexin system. In addition, freezing
and the startle response are incompatible behavioral responses
associated with fear (Davis and Astrachan, 1978). Since the startle
response is often considered a measure of arousal (Lang and
Davis, 2006), it is possible that arousal peptides like orexins may
be preferentially involved in fear potential startle.
Exposure of rats to a single and brief episode of moderately
intense footshocks (1.5 mA) results in an increase in the levels
of prepro-orexin mRNA in the hypothalamus and systemic
treatment of shocked rats with a DORA reduce contextual fear
and the anxiety displayed by shocked rats tested in the elevated T
maze (Chen et al., 2014b). In this study, we tested the hypothesis
that blocking of orexin receptors in the PVT would attenuate
the expression of contextual fear. This hypothesis was based
on findings that blocking of OX2R in the PVT decreased the
anxiety of rats tested in the elevated plus maze and made anxious
by exposure to one 2.0 mA footshock for 10 s 2 days earlier
(Li et al., 2010b). Contrary to our hypothesis, injections of the
DORA in the PVT region had no effect on contextual fear.
The anxiety tests in experiment 2 were conducted to verify that
the microinjections of the DORA blocked orexin receptors in
the PVT. Indeed, the moderate and high doses of the DORA
had anxiolytic effects in the social interaction test. These results
indicate that orexin receptors in the PVT are not involved in
contextual fear but that these receptors play a role in regulating
anxiety. Our observation that injection of the highest dose of
the DORA in the PVT had a trend towards being anxiolytic
when rats were tested in the open field suggests a preferential
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recruitment of orexin receptors in the PVT in social anxiety. The
anxiolytic effects of blocking orexin receptors in the PVT have
been previously reported (Li et al., 2010b), which is consistent
with similar anxiolytic effects reported when orexin antagonists
are administered via systemic routes (Chen et al., 2014b; Viviani
et al., 2015). In these experiments, exposure of rats to relatively
high footshock intensity (1.5–2.0 mA) led to an orexin-mediated
anxiety. The fact that contextual fear learning was impaired
in knockout mice and that systemic injection of a DORA
attenuated some measures of contextual fear (Furlong et al.,
2009; Chen et al., 2014b) indicates that orexins are involved in
contextual fear but not through actions on orexin receptors in
the PVT.
These findings should also be viewed from the perspective that
other research showing that blocking of orexin receptors in the
PVT has anxiolytic effect (Li et al., 2010a,b; Heydendael et al.,
2011). A dose dependent decrease in the latency in the social
interaction test indicates that microinjections of the DORA in
the PVT produced a previously characterized pharmacological
effect for orexin receptors in this area of the thalamus. As
such, the negative results associated with the fear conditioning
experiments in the present study are unlikely due to inadequate
antagonism of orexin receptors in the PVT. The fact that
injections of a DORA in the PVT attenuated anxiety while having
no effect on learned fear also suggests that activation of orexin
receptors in the PVT leads to a recruitment of brain pathways or
mechanisms related to anxiety.
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